Chargement en cours...
A case–control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
GARDASIL (Merck & Co., Inc., Whitehouse Station, NJ, USA) is a quadrivalent human papillomavirus (HPV4) vaccine. An epidemiological study was undertaken to evaluate concerns about the potential for HPV4 vaccination to induce serious autoimmune adverse events (SAAEs). The vaccine adverse event re...
Enregistré dans:
| Publié dans: | Clin Rheumatol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer London
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4475239/ https://ncbi.nlm.nih.gov/pubmed/25535199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-014-2846-1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|